Modulation of Metabotropic Glutamate Receptors as a Strategy to Improve the Efficacy and Safety of Ketamine as an Antidepressant
Since the introduction of the NMDA receptor antagonist (<i>S</i>)-ketamine for depression therapy, it has become evident that the glutamatergic hypothesis of depression, proposed over 20 years ago, was justified and based on solid foundations. A significant breakthrough with this drug is its ability...
Gardado en:
| Autor Principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2025-12-01
|
| Series: | Cells |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/2073-4409/14/24/1967 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|